Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2007
12/19/2007EP0594669B2 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
12/19/2007CN101090729A Antibodies and related molecules that bind to psca proteins
12/18/2007US7309814 Nucleic acid molecules encoding bacterial autoinducer inactivation protein as targets for engineering disease resistance
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309569 Nucleotide sequence complex nucleobase binding; rational drug design; telomerase/enzyme inhibitors; antitumor agents
12/18/2007CA1341566C Immune response to tumors induced by anti-idiotype antibodies
12/13/2007WO2005017103A3 Bacterial nitric oxide synthases and uses thereof
12/13/2007WO2005005602A3 Methods for the identification of inhibitors of fumarate reductase and vacuolar protein sorting-associated protein as antibiotics
12/13/2007US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
12/13/2007US20070286852 Sppls as Modifiers of the P53 Pathway and Methods of Use
12/12/2007EP1639089A4 Transcription factor
12/12/2007EP1546387A4 Microarray synthesis and assembly of gene-length polynucleotides
12/12/2007EP1144454B1 Modified peptides as therapeutic agents
12/11/2007US7307154 DNA encoding a novel RG1 polypeptide
12/06/2007WO2005044994A3 High temperature and alkaline stable catalase
12/06/2007WO2005033277A3 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase
12/06/2007WO2004092344A3 A method for preparing para-hydroxystyrene by biocatalytic decarboxylation of para-hydroxycinnamic acid in a biphasic reaction medium
12/06/2007WO2004074460A3 Nucleotide and protein sequences of coc genes and methods based thereon
12/06/2007US20070280985 Methods of Establishing Intercellular Communication in an Endothelial Cell Layer and Uses Thereof
12/05/2007EP1862626A1 Novel trichoderma genes
12/05/2007EP1862544A1 Polypeptides capable of eliciting an immune reaction against cancer
12/05/2007EP1862540A1 Novel trichoderma genes
12/05/2007EP1862539A1 Novel trichoderma genes
12/05/2007EP1675943A4 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
12/05/2007CN101084509A Methods of identifying and designing cell surface receptor inhibitors
12/05/2007CN101082050A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
12/05/2007CN101082049A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
12/05/2007CN101081869A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081868A Humanized antibodies that recognize beta amyloid peptide
12/05/2007CN101081867A Humanized antibodies that recognize beta amyloid peptide
12/04/2007US7304220 Regulation of quinolate phosphoribosyl transferase expression
12/04/2007US7304139 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
12/04/2007US7303694 crystals that exhibit low toxicity towards cells such as 4'-(3,4-difluorophenyl)-4-propylbicyclohexyl; methods of analyzing cells using liquid crystals; contacting solution of liquid crystal, and a biomolecule with surface that uniformly orients liquid crystal when biomolecule does not bind receptor
12/04/2007CA1341565C Protection of plants against viral infection
11/2007
11/29/2007WO2005003294A3 Unnatural reactive amino acid genetic code additions
11/29/2007WO2004113496A3 Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation
11/29/2007WO2004111187A3 Methods for identification of coronaviruses
11/29/2007US20070276049 Inhibiting cell membrane-mediated effects of infectious microorganisms using a family of glycerol-based compounds such as glycerol monolaurate (GML)
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275400 Multivariate Random Search Method With Multiple Starts and Early Stop For Identification Of Differentially Expressed Genes Based On Microarray Data
11/29/2007US20070275381 Nucleotide sequences coding variant microsatellite markers for use as tool in diagnosing learning disabilities
11/29/2007US20070275010 Mva Vaccines
11/29/2007US20070274914 Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
11/29/2007US20070274912 Histone Modifications as Binary Switches Controlling Gene Expression
11/29/2007US20070272998 Semiconductor Device
11/28/2007EP1860186A2 Method for distinguishing mesenchymal stem cells using different markers
11/28/2007EP1625199A4 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
11/28/2007EP1622923A4 Molecular detection systems utilizing reiterative oligonucleotide synthesis
11/28/2007EP1412486B1 Method for virus propagation
11/28/2007CN101080499A Genomic screen for epigenetically silenced tumor suppressor genes
11/28/2007CN101078017A Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
11/28/2007CN101078016A Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
11/27/2007US7301017 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
11/27/2007CA2380872C Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/22/2007WO2005044995A3 Uses of human peptide deformylase
11/22/2007WO2005035716A3 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
11/22/2007WO2004108894A3 Methods and compositions for amino acid production
11/22/2007WO2004101765A3 Methods and apparatus for adeno associated virus purification
11/22/2007WO2004099388A3 Cbl-b polypeptides, complexes and related methods
11/22/2007US20070270504 Identification of Therapeutic Agents Using Genetic Fingerprinting
11/22/2007US20070269874 based on the effects of sulfur-deprivation on algal photosynthesis and physical separation of the net O2 and H2 production processes in algal cultures;
11/22/2007US20070269802 Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of Use
11/21/2007EP1670513A4 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy
11/21/2007EP1525466A4 Transgenic mammals expressing polyglutamine
11/21/2007CN101076599A Surface expression of biologically active proteins in bacteria
11/21/2007CN101076598A Compositions of orthogonal glutamyl-tRNA and aminoacyl tRNA synthetase pairs and uses thereof
11/21/2007CN101076585A Bacterial strains, compositions including same and probiotic use thereof
11/21/2007CN101074441A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/20/2007US7297503 Methods of identifying reduced internalization transmembrane receptor agonists
11/20/2007CA1341561C Manufacture and expression of large structural genes
11/15/2007WO2005044986A3 Methods and compositions for detection of segmented negative strand rna viruses
11/15/2007WO2005040351A3 Compositions for inducing cell growth and differentiation and methods of using same
11/15/2007WO2005021709A3 Cln101 antibodies
11/15/2007WO2005017105A3 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
11/15/2007US20070264666 High density sequence detection methods
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/14/2007EP1670895A4 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
11/14/2007EP1644533A4 Assay and process for labeling and detection of micro rna and small interfering rna sequences
11/14/2007CN101072788A Antisense oligonucleotides against PLA2, compositions and uses thereof
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
11/08/2007WO2005071058A3 Methods and systems for annotating biomolecular sequences
11/08/2007WO2005001058A3 Identification of biomarkers for liver toxicity
11/08/2007US20070261137 polynucleotide for controlling plant phenotype; producing a plant that expresses the cellulose synthase-encoding polynucleotides
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/08/2007US20070259403 Hla-E Chimeric Molecule
11/08/2007US20070258962 Plasmid comprising murine cytomegalovirus intermediate early 2 (mCMV-IE2) promoter for enhancing heterologous gene transcription; gene therapy and genetic engineering
11/08/2007US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/07/2007EP1711812A4 Methods and materials for canine breed identification
11/07/2007EP1639081A4 Compositions and methods for regulating polysaccharides of a plant cell
11/07/2007EP1623044A4 Methods for amplification of nucleic acid sequences using staggered ligation
11/07/2007EP1615992A4 Prion protein binding materials and methods of use
11/07/2007CN101068934A Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
11/07/2007CN101066447A Group b streptococcus proteins, and their use
11/07/2007CN100347301C Selection marker gene free recombinant strains: a method for obtaining them and the use of these strains
11/01/2007US20070254961 Polyisoprenylated Benzophenones and Their Isomers as Inhibitors of Histone Acetyltransferases and Uses thereof
11/01/2007US20070254356 Cell culture methods and devices utilizing gas permeable materials
11/01/2007US20070254343 using a polymerase extension reaction; elongation of an initial polynucleotide along a template oligonucleotide which has a 3' portion complementary to a 3' portion of the initial polynucleotide; template oligonucleotide can comprise a 3'-terminal blocker to prevent extension of the template
11/01/2007US20070253979 Whole killed HIV virus devoid of outer envelope protein; incomplete Freund's Adjuvant; enhance beta chemokine levels, interferon gamma, cytotoxic T lymphocyte response; slows progression to AIDS; reduces viral burden; infant, child, pregnant; administer subcutaneously, intramuscularly, intramucosally
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253953 Molecular Signature of the Pten Tumor Suppressor
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 100